DK528284D0 - 1-(2-aryl-2-halogen-1-ethenyl)-1h-azoler og fremgangsmaade til fremstilling deraf - Google Patents

1-(2-aryl-2-halogen-1-ethenyl)-1h-azoler og fremgangsmaade til fremstilling deraf

Info

Publication number
DK528284D0
DK528284D0 DK528284A DK528284A DK528284D0 DK 528284 D0 DK528284 D0 DK 528284D0 DK 528284 A DK528284 A DK 528284A DK 528284 A DK528284 A DK 528284A DK 528284 D0 DK528284 D0 DK 528284D0
Authority
DK
Denmark
Prior art keywords
azoles
ethenyl
aryl
halogen
procedures
Prior art date
Application number
DK528284A
Other languages
English (en)
Other versions
DK162984C (da
DK162984B (da
DK528284A (da
Inventor
Jan Heeres
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK528284D0 publication Critical patent/DK528284D0/da
Publication of DK528284A publication Critical patent/DK528284A/da
Publication of DK162984B publication Critical patent/DK162984B/da
Application granted granted Critical
Publication of DK162984C publication Critical patent/DK162984C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK528284A 1983-11-07 1984-11-06 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse DK162984C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54912783A 1983-11-07 1983-11-07
US54912783 1983-11-07
US63015884 1984-07-12
US06/630,158 US4539325A (en) 1983-11-07 1984-07-12 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof

Publications (4)

Publication Number Publication Date
DK528284D0 true DK528284D0 (da) 1984-11-06
DK528284A DK528284A (da) 1985-05-08
DK162984B DK162984B (da) 1992-01-06
DK162984C DK162984C (da) 1992-06-01

Family

ID=27069019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528284A DK162984C (da) 1983-11-07 1984-11-06 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse

Country Status (17)

Country Link
US (1) US4539325A (da)
EP (1) EP0142190B1 (da)
JP (1) JPH0613480B2 (da)
AU (1) AU566022B2 (da)
CA (1) CA1241657A (da)
CS (1) CS382091A3 (da)
CY (1) CY1606A (da)
DE (1) DE3478743D1 (da)
DK (1) DK162984C (da)
FI (1) FI85854C (da)
HK (1) HK52591A (da)
IE (1) IE57826B1 (da)
IL (1) IL73425A (da)
NO (1) NO161800C (da)
NZ (1) NZ210014A (da)
SG (1) SG46991G (da)
SU (1) SU1322978A3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149426B1 (de) * 1983-12-20 1988-05-04 Ciba-Geigy Ag Mikrobizide
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd N−ビニルアゾ−ル類
JP2792694B2 (ja) * 1989-12-12 1998-09-03 エスケ−化研株式会社 塗布装置
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
US5418245A (en) * 1990-04-16 1995-05-23 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
AU2002221222A1 (en) * 2000-12-04 2002-06-18 Biovitrum Ab Novel method and use
SE0004462D0 (sv) 2000-12-04 2000-12-04 Pharmacia Ab Novel method and use
RU2632682C1 (ru) * 2016-09-30 2017-10-09 Федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Комплекс ацетата цинка с 1-пропаргилимидазолом, обладающий антигипоксической активностью

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679697A (en) * 1970-10-08 1972-07-25 Searle & Co 1-({62 -halophenethyl)imidazoles
GB1533705A (en) * 1975-03-10 1978-11-29 Ici Ltd Method of combating fungal infections in plants using imidazoles and 1,2,4-triazoles
DE2839388A1 (de) * 1978-09-11 1980-03-27 Siegfried Ag Imidazolylvinylaether und deren verwendung
NL8005204A (nl) * 1980-09-17 1982-04-16 Gist Brocades Nv Ethenyl-imidazool-derivaten met antimycotische werkzaamheid.
GR78234B (da) * 1981-03-10 1984-09-26 Ciba Geigy Ag
CA1189857A (en) * 1981-03-27 1985-07-02 Janssen Pharmaceutica Naamloze Vennootschap Antimicrobial triazole derivatives
CA1206970A (en) * 1981-10-01 1986-07-02 Hak-Foon Chan Substituted ethylenic imidazoles and triazoles

Also Published As

Publication number Publication date
HK52591A (en) 1991-07-19
FI844349A0 (fi) 1984-11-06
FI85854C (fi) 1992-06-10
CY1606A (en) 1992-04-03
EP0142190A2 (en) 1985-05-22
FI85854B (fi) 1992-02-28
NO161800C (no) 1989-09-27
NO161800B (no) 1989-06-19
AU3513784A (en) 1985-05-16
US4539325A (en) 1985-09-03
SU1322978A3 (ru) 1987-07-07
CS382091A3 (en) 1992-04-15
AU566022B2 (en) 1987-10-08
IE842852L (en) 1985-05-07
EP0142190B1 (en) 1989-06-21
IL73425A (en) 1987-09-16
SG46991G (en) 1991-07-26
NZ210014A (en) 1987-03-06
DK162984C (da) 1992-06-01
IE57826B1 (en) 1993-04-21
JPH0613480B2 (ja) 1994-02-23
FI844349L (fi) 1985-05-08
IL73425A0 (en) 1985-02-28
DK162984B (da) 1992-01-06
EP0142190A3 (en) 1986-12-03
JPS60166666A (ja) 1985-08-29
DK528284A (da) 1985-05-08
NO844420L (no) 1985-05-08
DE3478743D1 (de) 1989-07-27
CA1241657A (en) 1988-09-06

Similar Documents

Publication Publication Date Title
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK298084A (da) Termistorer og fremgangsmaade til fremstilling deraf
DK112984A (da) Naphthalenyl- og tetrahydronaphthalenylimidazoler og fremgangsmaade til fremstilling deraf
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK493884A (da) Halogenholdigt blegemiddel og fremgangsmaade til fremstilling deraf
DK528284A (da) 1-(2-aryl-2-halogen-1-ethenyl)-1h-azoler og fremgangsmaade til fremstilling deraf
DK621484A (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK395084A (da) Quinoloner og fremgangsmaade til fremstilling deraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK184784A (da) Konjugerede filamenter og fremgangsmaade til fremstilling heraf
DK445784A (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK135684D0 (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK26384A (da) Toxoplasmosefaktor og fremgangsmaade til fremstilling deraf
DK467984D0 (da) 4-alkylmethylendioxy-2-1(h)-quinazolinoner og fremgangsmaade til fremstilling deraf
DK81192D0 (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684D0 (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK284184D0 (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
DK112682A (da) Azaspiroalkandioner og fremgangsmaade til fremstilling deraf
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
DK596884D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf